Rise Therapeutics
Phase 1At Rise Therapeutics, we develop targeted immunological-based biologics using a unique and proprietary oral delivery platform. We design and produce unique, fir
Founded
2018
Focus
BiologicsDrug Delivery
About
At Rise Therapeutics, we develop targeted immunological-based biologics using a unique and proprietary oral delivery platform. We design and produce unique, fir
Funding History
2Total raised: $30M
Series A$25MAlexandria Venture InvestmentsMay 15, 2022
Seed$5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationRockville, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile